Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Deficits
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2019 $ 9,392 $ 69,560,529 $ (23,271,687) $ (482,639) $ 45,815,595
Balance (in Shares) at Dec. 31, 2019 9,391,729        
Stock compensation expense 464,827 464,827
Revaluation of stock warrant (66,200) (66,200)
Other comprehensive income (loss) 343,775 343,775
Net loss for the period (2,366,494) (2,366,494)
Balance (Unaudited) at Mar. 31, 2020 $ 9,392 69,959,156 (25,638,181) (138,864) 44,191,503
Balance (Unaudited) (in Shares) at Mar. 31, 2020 9,391,729        
Stock compensation expense 448,987 448,987
Revaluation of stock warrant 455,500 455,500
Other comprehensive income (loss) (571,592) (571,592)
Net loss for the period (2,121,206) (2,121,206)
Balance (Unaudited) at Jun. 30, 2020 $ 9,392 70,863,643 (27,759,387) (710,456) 42,403,192
Balance (Unaudited) (in Shares) at Jun. 30, 2020 9,391,729        
Balance at Dec. 31, 2020 $ 9,488 73,160,616 (32,383,833) (1,754,228) 39,032,043
Balance (in Shares) at Dec. 31, 2020 9,487,889        
Stock compensation expense 1,680,365 1,680,365
Revaluation of stock warrant (355,600) (355,600)
Other comprehensive income (loss) 393,767 393,767
Net loss for the period (4,228,126) (4,228,126)
Balance (Unaudited) at Mar. 31, 2021 $ 9,488 74,485,381 (36,611,959) (1,360,461) 36,522,449
Balance (Unaudited) (in Shares) at Mar. 31, 2021 9,487,889        
Stock compensation expense 179,331 179,331
Revaluation of stock warrant (42,000) (42,000)
Other comprehensive income (loss) (524,181) (524,181)
Net loss for the period (1,535,901) (1,535,901)
Balance (Unaudited) at Jun. 30, 2021 $ 9,488 $ 74,622,712 $ (38,147,860) $ (1,884,642) $ 34,599,698
Balance (Unaudited) (in Shares) at Jun. 30, 2021 9,487,889